Literature DB >> 24452870

Risk profiles for metabolic syndrome and its transition patterns for the elderly in Beijing, 1992-2009.

Li-Xin Tao1, Wei Wang, Hui-Ping Zhu, Da Huo, Tao Zhou, Lei Pan, Qi Gao, Yan-Xia Luo, Li-Juan Wu, Xia Li, Zhe Tang, Xiu-Hua Guo.   

Abstract

There have been few reports on the development of metabolic disorders, especially when they are considered as a cluster. The purpose of this study was to describe risk profiles for metabolic syndrome (MetS) in elderly dwellers in Beijing, and to find their transition patterns over time. Data were derived from Beijing longitudinal study of aging, a community-based cohort study hosted by Xuanwu hospital. There were 3,257 elderly people aged 55 years or over recruited in 1992. MetS was assessed for the years 1992, 2000, and 2009. Finally, 363 subjects with complete information for components of MetS in the three years were included in the study. The criteria of MetS recommended by the joint interim statement criteria were adopted. Latent transition analysis was used to calculate the transition probabilities between adjacent visits. A risk typology consisting of four time-invariant groups was detected based on the components of MetS for all subjects. Low MetS risk group, BP risk group, BP-HDL risk group, and BP-FPG-TG risk group were found. The probability of staying at the same status was higher at the two intervals across 18 years. Four latent groups were extracted based on three assessments for the components of MetS, together with their transition patterns. Findings suggested various trajectories for MetS components. Different combinations of intervention strategy might be needed for MetS risk groups.

Entities:  

Mesh:

Year:  2014        PMID: 24452870     DOI: 10.1007/s12020-013-0143-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  30 in total

1.  The guidelines for prevention and control of overweight and obesity in Chinese adults.

Authors:  Chunming Chen; Frank C Lu
Journal:  Biomed Environ Sci       Date:  2004       Impact factor: 3.118

2.  A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand.

Authors:  Supachai Tanomsup; Wichai Aekplakorn; Piyamitr Sritara; Mark Woodward; Sukit Yamwong; Supoch Tunlayadechanont; Aninthita Tatsaneeyapan; Stephen Lim; Rajata Rajatanavin
Journal:  Diabetes Care       Date:  2007-04-27       Impact factor: 19.112

3.  Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort.

Authors:  Masafumi Kuzuya; Fujiko Ando; Akihisa Iguchi; Hiroshi Shimokata
Journal:  Atherosclerosis       Date:  2006-07-07       Impact factor: 5.162

4.  Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?

Authors:  Fahim Abbasi; Christine Blasey; Gerald M Reaven
Journal:  Am J Clin Nutr       Date:  2013-07-24       Impact factor: 7.045

5.  Relationship between obesity and several cardiovascular disease risk factors in apparently healthy Korean individuals: comparison of body mass index and waist circumference.

Authors:  Ki Chul Sung; Seungho Ryu; Gerald M Reaven
Journal:  Metabolism       Date:  2007-03       Impact factor: 8.694

6.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

Review 7.  Role of insulin resistance in human disease (syndrome X): an expanded definition.

Authors:  G M Reaven
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

8.  Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study.

Authors:  Sol M Rodriguez-Colon; Jingping Mo; Yinkang Duan; Jiahao Liu; Joanne E Caulfield; Xuejuan Jin; Duanping Liao
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

9.  Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study.

Authors:  Ki-Chul C Sung; Mi-Hae H Seo; Eun-Jung J Rhee; Andrew M Wilson
Journal:  Cardiovasc Diabetol       Date:  2011-11-30       Impact factor: 9.951

10.  Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease.

Authors:  Alexander Vonbank; Christoph H Saely; Philipp Rein; Heinz Drexel
Journal:  Cardiovasc Diabetol       Date:  2013-07-17       Impact factor: 9.951

View more
  5 in total

1.  Dynamic behavior of metabolic syndrome progression: a comprehensive systematic review on recent discoveries.

Authors:  Pezhman Bagheri; Davood Khalili; Mozhgan Seif; Abbas Rezaianzadeh
Journal:  BMC Endocr Disord       Date:  2021-03-22       Impact factor: 2.763

2.  Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults.

Authors:  Xiangtong Liu; Lixin Tao; Kai Cao; Zhaoping Wang; Dongning Chen; Jin Guo; Huiping Zhu; Xinghua Yang; Youxin Wang; Jingjing Wang; Chao Wang; Long Liu; Xiuhua Guo
Journal:  BMC Public Health       Date:  2015-04-22       Impact factor: 3.295

3.  The Impact of BMI Categories on Metabolic Abnormality Development in Chinese Adults Who are Metabolically Healthy: A 7-Year Prospective Study.

Authors:  Xiangtong Liu; Jingbo Zhang; Jingwei Wu; Xiaolin Xu; Lixin Tao; Yue Sun; Shuo Chen; Yumei Han; Yanxia Luo; Xinghua Yang; Xiuhua Guo
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-19       Impact factor: 3.168

4.  Predicting the natural history of metabolic syndrome with a Markov-system dynamic model: a novel approach.

Authors:  Abbas Rezaianzadeh; Esmaeil Khedmati Morasae; Davood Khalili; Mozhgan Seif; Ehsan Bahramali; Fereidoun Azizi; Pezhman Bagheri
Journal:  BMC Med Res Methodol       Date:  2021-11-27       Impact factor: 4.615

5.  Dynamic development of metabolic syndrome and its risk prediction in Chinese population: a longitudinal study using Markov model.

Authors:  Xiaoxian Jia; Qicai Chen; Peipei Wu; Meng Liu; Xiaoxiao Chen; Juan Xiao; Lili Chen; Pengpeng Zhang; Shumei Wang
Journal:  Diabetol Metab Syndr       Date:  2018-04-02       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.